Novo Nordisk's pricing approaches inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of value gouging, stating the stark distinction involving U.S. rates and those in Europe and copyright.Comprehension the generation prices is important for any person looking to navigate the complexities of